Rheumatology

Bisphosphonates, raloxifene and teriparatide for treating osteoporosis

This summary is based on 3 recent NICE guidelines: Bisphosphonates in people for primary or secondary prevention. Raloxifene for primary prevention. Basically it isn't advised. Raloxifene and teriparatide for secondary prevention. The advice hasn't changed. Previous guidance was rather complicated in that different bisphosphonates could be used at different levels of risk. This has all…
Read more

Nice | Osteoarthritis

This guideline from NICE is an update of their 2008 osteoarthritis one. There will be more coming soon on pharmacological treatments, so this is covering most of the other stuff. There is only 1 new thing for us, which is in diagnosis. There isn't much else new, but as this is such a common condition, I'll give…
Read more